2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
FDA Comment Number : EC807
Submitter : Dr. Judith McGuinn Date & Time: 10/13/2005 09:10:40
Organization : Dr. Judith McGuinn
Category : Health Professional
Issue Areas/Comments
It is inconceivable that the FDA would allow over the counter sales of the "morning after" pill. The drug has dangerous and potentially lethal side effects. Even though these will be listed, the desperate woman will take no heed.